DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hzr4x9/opportunityanalyze) has announced the addition of the "OpportunityAnalyzer: Gaucher Disease - Opportunity Analysis and Forecast to 2024" report to their offering.
The report estimates the Gaucher Disease market will be worth $1.16 billion by 2024.
Key Topics Covered:
- Overview of GD, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.
- Annualized GD therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2014 and forecast for ten years to 2024.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the GD therapeutics market.
- Pipeline analysis: comprehensive data split across different phases, emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.
Benefits of this Report:
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.
- Develop business strategies by understanding the trends shaping and driving the GD therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the GD therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Track drug sales in the 7MM GD therapeutics market from 2014-2024.
- Belrose Pharma
1.1 List of Tables
1.2 List of Figures
3 Disease Overview
5 Current Treatment Options
6 Unmet Needs Assessment and Oppportunity Analysis
7 R&D Strategies
8 Pipeline Assessment
9 Pipeline Valuation Analysis
For more information visit http://www.researchandmarkets.com/research/hzr4x9/opportunityanalyze